Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 308 entries
View as:

Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).

Phase: N/A Priority: Normal
NCT ID: NCT00741325 Org: User:
Start: 06/30/06 End: 11/30/11 Due: 11/30/12

Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.

Phase: N/A Priority: Normal
NCT ID: NCT00813397 Org: User:
Start: 09/30/08 End: 07/31/09 Due: 07/31/10

Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT01674036 Org: User:
Start: 08/31/12 End: 01/31/13 Due: 01/31/14

A Study of the Safety and Efficacy of Patients With Familial Hypercholesterolaemia Taking Colesevelam as add-on Therapy to Their Existing Medication

Phase: N/A Priority: Normal
NCT ID: NCT00655265 Org: User:
Start: 08/31/07 End: 10/31/09 Due: 10/31/10

A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)

Phase: N/A Priority: Normal
NCT ID: NCT00417469 Org: User:
Start: 01/31/07 End: 02/28/07 Due: 02/28/08

A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00358956 Org: User:
Start: 08/31/06 End: 05/31/14 Due: 05/31/15

A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT02282826 Org: User:
Start: 10/31/14 End: 03/31/16 Due: 03/31/17

ZD6474(Vandetanib) + Alimta Combo Study

Phase: N/A Priority: Normal
NCT ID: NCT00506051 Org: User:
Start: 07/31/05 End: 10/31/11 Due: 10/31/12

Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT01736150 Org: User:
Start: 03/31/10 End: 09/30/10 Due: 09/30/11

Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00322842 Org: User:
Start: 09/30/04 End: 02/28/07 Due: 02/28/08

A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT00046696 Org: User:
Start: 05/31/01 End: 10/31/06 Due: 10/31/07

Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00686036 Org: User:
Start: 05/31/08 End: 10/31/10 Due: 10/31/11

Evaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical Adhesions

Phase: N/A Priority: Normal
NCT ID: NCT00665730 Org: User:
Start: 07/31/07 End: 06/30/08 Due: 06/30/09

ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures

Phase: N/A Priority: Normal
NCT ID: NCT00404924 Org: User:
Start: 11/30/06 End: 11/30/14 Due: 11/30/15

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00034918 Org: User:
Start: 05/31/02 End: 11/30/03 Due: 11/30/04

ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00312377 Org: User:
Start: 05/31/06 End: 03/31/14 Due: 03/31/15

Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine

Phase: N/A Priority: Normal
NCT ID: NCT00753714 Org: User:
Start: 10/31/08 End: 12/31/11 Due: 12/31/12

Avalglucosidase Alfa French Post-trial Access for Participants With Pompe Disease (PTA Avalglucosidase)

Phase: N/A Priority: Normal
NCT ID: NCT05164055 Org: User:
Start: 07/11/22 End: 12/31/25 Due: 12/31/26

Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00044889 Org: User:
Start: 05/31/02 End: 03/31/03 Due: 03/31/04

Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe Disease

Phase: N/A Priority: Normal
NCT ID: NCT00025896 Org: User:
Start: 05/31/01 End: 09/30/02 Due: 09/30/03

An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT00681941 Org: User:
Start: 01/31/06 End: 03/31/07 Due: 03/31/08

A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesteremia

Phase: N/A Priority: Normal
NCT ID: NCT00690937 Org: User:
Start: 02/29/08 End: 12/31/08 Due: 12/31/09

Study to Evaluate the Effect of Eliglustat on the Pharmacokinetics, Safety and Tolerability of Metoprolol in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01659944 Org: User:
Start: 05/31/12 End: 07/31/12 Due: 07/31/13

Study of Sargramostim in Moderately to Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00329537 Org: User:
Start: 06/30/06 End: 05/31/07 Due: 05/31/08

An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone Mass

Phase: N/A Priority: Normal
NCT ID: NCT00078026 Org: User:
Start: 08/31/03 End: 12/31/04 Due: 12/31/05